Clinical Trial Update: Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cytarabine and daunorubicin or idarubicin with or without vorinostat for younger patients with untreated acute myeloid leukemia has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Vorinostat (vorinostat)
• cytarabine and daunorubicin hydrochloride (cytarabine and daunorubicin hydrochloride)
• idarubicin and cytarabine (idarubicin and cytarabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2018-12-19